What is a major risk associated with the concurrent use of NSAIDs and anticoagulants?

• A. Lower blood pressure
• B. Increased risk of gastrointestinal bleeding
• C. Enhanced sedative effects
• D. Improved blood clotting

Answer: (B)

The concurrent use of NSAIDs and anticoagulants significantly increases the risk of gastrointestinal bleeding. Both classes of medications can irritate the gastrointestinal (GI) lining, and when used together, their effects can be compounded. NSAIDs inhibit the production of prostaglandins, which protect the stomach lining and support mucosal integrity. Anticoagulants, on the other hand, work by thinning the blood to prevent clots, which can also result in increased bleeding.

When these two types of drugs are taken simultaneously, the likelihood of developing erosions or ulcers in the GI tract is heightened. If bleeding occurs, it can lead to serious complications, including significant blood loss and the potential need for surgical intervention.

Understanding this risk is crucial for healthcare providers and patients alike, as these two medication classes can be commonly prescribed. Thus, measures should be taken to monitor for signs of GI issues and consider alternative therapies or protective agents, like proton pump inhibitors, when they are used together.